Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 12/20 | 0.78 |
| ▸ | BACE1 | P56817 | 12/20 | 0.78 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.76 |
| ▸ | ENPP1 | P22413 | 3/20 | 0.70 |
| ▸ | AURKA | O14965 | 3/20 | 0.66 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5518977 | 0.98 | ACHE (0.76) | ACHEBACE1PDE10AENPP1AURKA | |
| SCHEMBL11882354 | 0.94 | ACHE (0.88) | ACHEBACE1PDE10AENPP1AURKA | |
| SCHEMBL29357509 | 0.91 | ACHE (0.66) | ACHEBACE1PDE10AENPP1AURKA | |
| SCHEMBL4779574 | 0.88 | ACHE (0.63) | ACHEBACE1PDE10AENPP1AURKA | |
| SCHEMBL5525750 | 0.88 | ACHE (0.74) | ACHEBACE1PDE10AENPP1AURKA | |
| SCHEMBL13790502 | 0.88 | ACHE (1.00) | ACHEBACE1PDE10AENPP1AURKA | |
| SCHEMBL24510065 | 0.88 | ACHE (0.66) | ACHEBACE1PDE10AENPP1AURKA | |
| SCHEMBL2921150 | 0.88 | ENPP1 (0.77) | ACHEBACE1PDE10AENPP1AURKA | |
| SCHEMBL30515263 | 0.88 | ACHE (0.66) | ACHEBACE1PDE10AENPP1AURKA | |
| SCHEMBL30080059 | 0.88 | ENPP1 (0.77) | ACHEBACE1PDE10AENPP1AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009090004-A1 | PHOSPHODIESTERASE 10 CATALYTIC DOMAIN CRYSTALS | F.HOFFMANN-LA ROCHE AG (CH) | 2009-07-23 | — | — | WO | disclosed |
| CN-101242838-A | Synergistic modulation of FLT3 kinase using aminoquinoline and aminoquinazoline kinase modulators | JANSSEN PHARMACEUTICA NV (BE) | 2008-08-13 | — | — | CN | disclosed |